Focused Orticumab Research for Treating Inflammation in Coronary Arteries

Clinical trial NCT06927739 · RECRUITING

Trial details

NCT number: NCT06927739
Sponsor: Abcentra
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Coronary Syndromes Coronary Arterial Disease (CAD)Inflammation Heart Disease Myocardial Infarct Atherosclerotic Coronary Vascular Disease

Start date: 2025-08-11
Primary completion: 2027-02-08
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.